Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Alpha-methyl-DOPA

Thyroid supplement Blood pressure medications Beta blockers Thiazide diuretics Alpha methyl DOPA Appetite suppressants Phentermine Sibutramine Other Alcohol Caffeine Cocaine Nicotine... [Pg.265]

P. Juvancz, The sleep of artificially reared newborn rats, effect of alpha-methyl-dopa treatment on paradoxical sleep and on adult behaviour, Acta Physiol. Acad. Sci. Hung., 57(1) (1981) 87-98. [Pg.310]

Carlsson A, Dahlstroem A, Fuxe K, Hillarp NA (1965) Failure of reserpine to deplete noradrenaline neurons of alpha-methylnoradrenaline formed from alpha-methyl dopa. Acta Pharmacol Toxicol (Copenh) 22 270-276. [Pg.99]

Harrison, W. H., Gray, R. H., and Solomon, L. M., Incorporation of L-dopa, L-alpha-methyl-dopa and DL-isoproterenol into guinea-pig hair, Acta Derm. Venereal, 54, 249, 1974. [Pg.210]

Acebutolol Alpha-methyl-dopa Captopril Carbimazole Chlorpromazine Dihydralazine Fludarabine Hydralazine Infliximab Interferons-alpha Iproniazid Isoniazid Nomifensine Penicillamine D-Penicillamine Practolol Procainamide Propylthiouracil rlL-2 Simvastatin Tienilic acid Tryptophan contaminants Zimeldine Lupus syndrome Autoimmune haemolytic anaemia Pemphigus ANCA-associated vasculitis Lupus syndrome Autoimmune hepatitis Autoimmune haemolytic anaemia Lupus syndrome, ANCA-associated vasculitis Lupus syndrome Wide range of autoimmune diseases Autoimmune hepatitis Lupus syndrome Autoimmune haemolytic anaemia Myasthenia, dermatomyositis Anti-GBM (Goodpasture) disease Oculocutaneomucous syndrome Lupus syndrome ANCA-associated vasculitis Autoimmune thyroiditis Lupus syndrome Autoimmune hepatitis Eosinophilia myalgia syndrome (see section 9.3.5) Guillain-Barre syndrome... [Pg.150]

Vertical dashed lines indicate blood pressure readings taken while patient was standing in erect position. Alpha-methyl-dopa did not control blood pressure in this patient, but did not produce postural hypotension seen with guanethidine... [Pg.77]

The higher narcotic potency in vivo of the S(-f )-isomer of hexobarbital was shown to be related to higher CNS levels than for the R( —) form, this seems to be due to an improved crossing of the blood-brain barrier (BBB). In a distribution study of (-1-)- and (— )-alpha-methyl-DOPA in the rat after intravenous injection, the (— )-isomer attained higher concentrations than the (-f)-form in most organs, in accordance with the fact that of the two isomers, only the (-) isomer has hypotensive activity. [Pg.281]

Alpha-methyl- DOPA (Aldomet) Decarboxylated to a-methyl dopamine then (3-hydroxylated to a-methyinorepinephrine, a potent a2 receptor agonist. Results in 4 mpathetic outflow from CNS. preganglionic sympathetic output, rapidly 4 blood pressure -but sympathetic system can respond with cardiac stimulation. Sedation, mild orthostatic hypotension, dry mouth, fever, nasal stuffiness, Coombs positive RBCs, salt and water retention, rebound hypertension. [Pg.20]

Mones RJ. Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy. N Y State JMed (1974) 74, 47-51. [Pg.688]

Lo Buglio AF, Jandl JH (1967) The nature of the alpha-methyl-dopa red-cell antibody. N Engl J Med 276 658... [Pg.128]

The rate of pregnancy-blocking is also reduced when the strange male belongs to an inbreeding strain or on administration of alpha-methyl dopa suggesting that dopaminergic nervous system are involved in the Bruce effect (338). [Pg.22]

Sahu, S.C., and C.J. Dominic Effect of alpha-Methyl Dopa Administration on the Pheromonal Block to Implantation in Mice. Curr. Sci. 52, 179-181 (1983). [Pg.72]

Fellinger, K., Grabner, G. and Krygicz, H., Voriaufiger Bericht iiber die klinische Wirksamkeit von /-Alpha-Methyl-Dopa (Aldomet) in der Behandlung der Hypertonie. Wien, Z. inn. Med. 42, 12, 527 (1961). [Pg.138]

The catecholamine-synthesizing enzymes are not only able to synthesize dopamine and norepinephrine from a physiologically occurring substrate such as L-dopa, but also from exogenous substrates such as alpha-methyldopa, which is converted to alpha-methyldopamine and in turn to alpha-methylnorepinephrine. Alpha-methyldopamine and alpha-methyl-norepinephrine are called false transmitters and, in general (except for alpha-methylnorepinephrine), are weaker agonists. Alpha-methyldopa is used in the management of hypertension. [Pg.137]

Methyldopa (l -pathway directly parallels the synthesis of norepinephrine from dopa illustrated in Figure 6-5. Alpha-methylnorepinephrine is stored in adrenergic nerve vesicles, where it stoichiometrically replaces norepinephrine, and is released by nerve stimulation to interact with postsynaptic adrenoceptors. Flowever, this replacement of norepinephrine by a false transmitter in peripheral neurons is not responsible for methyldopa s antihypertensive effect, because the a-methylnorepinephrine released is an effective agonist at the cx adrenoceptors that mediate peripheral sympathetic constriction of arterioles and venules. In fact, methyldopa s antihypertensive action appears to be due to stimulation of central a adrenoceptors by a-methylnorepinephrine or a-methyldopamine. [Pg.228]


See other pages where Alpha-methyl-DOPA is mentioned: [Pg.12]    [Pg.540]    [Pg.540]    [Pg.12]    [Pg.540]    [Pg.540]    [Pg.81]    [Pg.18]    [Pg.1035]    [Pg.509]    [Pg.494]    [Pg.1055]   
See also in sourсe #XX -- [ Pg.20 ]




SEARCH



Alpha-methyl

DOPA

Methyl dopa

© 2024 chempedia.info